LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Treatment Platform NeuroPace's world-first RNS System offers a neuromodulation solution for epilepsy that can monitor and respond to brain activity, making it a compelling choice for healthcare providers seeking advanced treatment options for neurological disorders.

Expanding Indications The company's recent FDA application to broaden RNS System indications to include idiopathic generalized epilepsy indicates a growth opportunity to serve a larger patient demographic.

Strong Market Position With a 24% revenue increase in Q4 2025 and a high insider ownership rate of nearly 79%, NeuroPace demonstrates robust growth momentum and committed stakeholder support, signaling a viable partnership for expanding device adoption.

Strategic Engagements Participation in major industry conferences like the J.P. Morgan Healthcare Conference offers multiple touchpoints to connect with key decision-makers, facilitating sales conversations and strategic collaborations.

Growing Customer Base The company's focus on treatment-resistant epilepsy presents multiple upsell and cross-sell opportunities within neurology clinics specializing in complex neurological conditions, supported by its innovative and proven therapy platform.

NeuroPace Tech Stack

NeuroPace uses 8 technology products and services including Varnish, CookieYes, Oracle Database, and more. Explore NeuroPace's tech stack below.

  • Varnish
    Caching
  • CookieYes
    Cookie Compliance
  • Oracle Database
    Database
  • Modernizr
    Javascript Libraries
  • Microsoft Azure
    Platform As A Service
  • JSON
    Programming Languages
  • HTML
    Programming Languages
  • Google Tag Manager for WordPress
    Web Platform Extensions

Media & News

NeuroPace's Email Address Formats

NeuroPace uses at least 1 format(s):
NeuroPace Email FormatsExamplePercentage
FLast@neuropace.comJDoe@neuropace.com
78%
Last@neuropace.comDoe@neuropace.com
19%
FMiddleLast@neuropace.comJMichaelDoe@neuropace.com
3%

Frequently Asked Questions

Where is NeuroPace's headquarters located?

Minus sign iconPlus sign iconNeuroPace's main headquarters is located at 455 North Bernardo Avenue Mountain View, California 94043 United States. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is NeuroPace's phone number?

Minus sign iconPlus sign icon You can contact NeuroPace's main corporate office by phone at
+1-650-237-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is NeuroPace's stock symbol?

Minus sign iconPlus sign iconNeuroPace is a publicly traded company; the company's stock symbol is NPCE.

What is NeuroPace's official website and social media links?

Minus sign iconPlus sign iconNeuroPace's official website is neuropace.com and has social profiles on LinkedInCrunchbase.

How much revenue does NeuroPace generate?

Minus sign iconPlus sign icon As of February 2026, NeuroPace's annual revenue is estimated to be $19M.

What is NeuroPace's SIC code NAICS code?

Minus sign iconPlus sign iconNeuroPace's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does NeuroPace have currently?

Minus sign iconPlus sign iconAs of February 2026, NeuroPace has approximately 234 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Financial Officer And Vice President: R. K.Vice President Of Marketing: K. K.Vice President Of Operation: A. D.. Explore NeuroPace's employee directory with LeadIQ.

What industry does NeuroPace belong to?

Minus sign iconPlus sign iconNeuroPace operates in the Medical Equipment Manufacturing industry.

What technology does NeuroPace use?

Minus sign iconPlus sign iconNeuroPace's tech stack includes VarnishCookieYesOracle DatabaseModernizrMicrosoft AzureJSONHTMLGoogle Tag Manager for WordPress.

What is NeuroPace's email format?

Minus sign iconPlus sign iconNeuroPace's email format typically follows the pattern of FLast@neuropace.com. Find more NeuroPace email formats with LeadIQ.

How much funding has NeuroPace raised to date?

Minus sign iconPlus sign icon As of February 2026, NeuroPace has raised $75M in funding. The last funding round occurred on Jun 04, 2025 for $75M.

When was NeuroPace founded?

Minus sign iconPlus sign iconNeuroPace was founded in 1999.

NeuroPace

Medical Equipment ManufacturingCalifornia, United States201-500 Employees

The RNS® System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the world's first and only medical device that can monitor and respond to brain activity.

NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.

Section iconCompany Overview

Headquarters
455 North Bernardo Avenue Mountain View, California 94043 United States
Phone number
+1-650-237-****
Website
neuropace.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
NPCE
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
1999
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $75M

    NeuroPace has raised a total of $75M of funding over 11 rounds. Their latest funding round was raised on Jun 04, 2025 in the amount of $75M.

  • $50M$100M

    NeuroPace's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $75M

    NeuroPace has raised a total of $75M of funding over 11 rounds. Their latest funding round was raised on Jun 04, 2025 in the amount of $75M.

  • $50M$100M

    NeuroPace's revenue is estimated to be in the range of $50M$100M

Company Leadership

  • Stylized image of a person
    R. K.
    Chief Financial Officer And Vice President
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. K.
    Vice President Of Marketing
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. D.
    Vice President Of Operation
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. B.
    President And Ceo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. M. D.
    Head Of Clinical Trial Operations
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    S. M.
    Company Owner
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. K.
    Vice President Of Marketing
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. M. D.
    Head Of Clinical Trial Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. D.
    Vice President Of Operation
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. W.
    Director Of Digital Marketing
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.